All Company Presentation submissions will be reviewed by the BIO Investor Forum Team.
Get the most out of the BIO Investor Forum by giving a 13-minute Company Presentation at the BIO Investor Forum.
Company Presentations are an integral programming element which allow you to showcase your company's pipeline, R&D activities, and future fundraising goals.
Get in front of an exclusive audience of public and private equity investors and venture capitalists, plus other biotech executives providing valuable exposure to companies poised to grow.
Please note that Companies that are approved to present must pay a Company Presentation fee in addition to being registered to attend the BIO Investor Forum.
In addition to presentation time during the event, Company Presentations include brand awareness benefits, such as:
- Your session and company profile listed in our event website program, with a link to your website and information about therapeutic areas
- Your representative included in the speaker list on the website
- Your session included in our Event App
- Inclusion in our printed schedule of Company Presentations distributed to all BIO Investor Forum Attendees
- Tag in the BIO One-on-One Partnering System as a Presenting Company
- Opportunity to submit materials to include in the session listing in the Event App
- Access to Social Media graphics to publicize your participation
Company Presentation Fees
These rates do not include registration (separate fee required - see below).
More information on how your company would be classified in registration.
Registration Fees
*All registrants are subject to approval.
**Partnering access is not included/provided with service provider registrations. To receive this benefit, please contact sponsor@bio.org for sponsorship opportunities.
Registration benefits are subject to change.
REGISTRATION CLASSIFICATIONS
REGISTRATION POLICIES
For the purposes of registration for any BIO event, conference or meeting, the classification of a registrant as a research and development company, an industry service provider, an academic & technology licensing officer or a qualifying investor is subject to review by BIO. In its sole discretion, BIO reserves the right to make the determination of the proper classification of a registrant. Depending on this classification, an additional registration fee may be required. BIO reserves the right to publish materials and restrict conference and/or partnering system access consistent with these determinations.